Cite Filings / INDP / 0001493152-22-025240

Feed Companies Filings Check

Sign in

CORRESP

Correspondence Between Filers and SEC Staff

Indaptus Therapeutics, Inc. Filed 2022-09-07 Acc 0001493152-22-025240

Documents 1

CORRESP Correspondence Between Filers and SEC Staff , filename1.htm

Around this filing

2022-12-30 CORRESP Correspondence Between Filers and SEC Staff
2022-09-09 EFFECT Notice of Effectiveness
2022-09-09 RW RW
2022-09-08 4 CEO and Director bought 9,692 shares at an average $2.56 ($24,771)
2022-09-07 CORRESP Correspondence Between Filers and SEC Staff
2022-09-07 UPLOAD SEC-generated Letter
2021-09-28 CORRESP Correspondence Between Filers and SEC Staff

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading filename1.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…